Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASHLAND INC.ASH · Entity 4139 | Director · Chief Executive Officer | November 18, 2019 | November 20, 2019 |
| AVIENT CORPAVNT · Entity 4061 | Director | September 30, 2026 | October 02, 2026 |
| Envoy Medical, Inc.ANZU · Entity 7161 | Director | March 01, 2021 | March 02, 2021 |
| MODINE MANUFACTURING COMOD · Entity 3547 | Director | August 21, 2025 | August 25, 2025 |
| VALVOLINE INCVVV · Entity 1678 | Director | November 15, 2017 | November 16, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASHLAND INC.
Report date November 18, 2019 · Filed November 20, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 125,406 |
Last balance in matching sequence
After 2019-11-18 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2019-11-18 · Exercise / conversion · Acquired 6,370 · Balance 143,679 F1: Balance includes 423 additional shares of Common Stock acquired in lieu of cash dividends (93 acquired on December 15, 2018, 99 acquired on March 15, 2019, 114 acquired on June 15, 2019, and 117 acquired on September 15, 2019). Row 2 · 2019-11-18 · Tax withholding · Disposed 3,077 · Balance 140,602 F2: Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units referenced in footnote 5 below, acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. F1: Balance includes 423 additional shares of Common Stock acquired in lieu of cash dividends (93 acquired on December 15, 2018, 99 acquired on March 15, 2019, 114 acquired on June 15, 2019, and 117 acquired on September 15, 2019). Row 3 · 2019-11-18 · Tax withholding · Disposed 15,196 · Balance 125,406 F3: Payment of tax liability by withholding securities incident to the vesting of performance based Restricted Stock granted 11/18/2015, acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. F1: Balance includes 423 additional shares of Common Stock acquired in lieu of cash dividends (93 acquired on December 15, 2018, 99 acquired on March 15, 2019, 114 acquired on June 15, 2019, and 117 acquired on September 15, 2019). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,926 |
Reported balance
After 2019-11-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-11-18 · Exercise / conversion · Disposed 6,370 · Balance 15,926 F4: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F5: Grant of Restricted Stock Units on November 16, 2016, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. F6: Balance also includes 452 restricted stock units acquired in lieu of cash dividends (100 acquired on December 15, 2018; 105 acquired on March 15, 2019; 122 acquired on June 15, 2019; and 125 acquired on September 15, 2019). |
Filing footnotes · ownership attribution and instrument terms
F1: Balance includes 423 additional shares of Common Stock acquired in lieu of cash dividends (93 acquired on December 15, 2018, 99 acquired on March 15, 2019, 114 acquired on June 15, 2019, and 117 acquired on September 15, 2019).
F2: Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units referenced in footnote 5 below, acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3.
F3: Payment of tax liability by withholding securities incident to the vesting of performance based Restricted Stock granted 11/18/2015, acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3.
F4: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
F5: Grant of Restricted Stock Units on November 16, 2016, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest in three equal annual installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer.
F6: Balance also includes 452 restricted stock units acquired in lieu of cash dividends (100 acquired on December 15, 2018; 105 acquired on March 15, 2019; 122 acquired on June 15, 2019; and 125 acquired on September 15, 2019).
AVIENT CORP
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDeferred Comp Plan | 67,044.281 |
Reported balance
After 2026-09-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 958 · Balance 67,044.281 F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors.
Envoy Medical, Inc.
Report date March 01, 2021 · Filed March 02, 2021
This filing explicitly reported no securities owned.
MODINE MANUFACTURING CO
Report date August 21, 2025 · Filed August 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 8,426 |
Reported balance
After 2025-08-21 transaction · row 1
1 source rowRow 1 · 2025-08-21 · Grant · Acquired 1,149 · Balance 8,426 F1: This is an award of restricted stock units that was deferred by the reporting person. Each restricted stock unit represents a right to receive one share of MOD common stock. Shares will be delivered to the reporting person based on the reporting person's deferral election applicable to the restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: This is an award of restricted stock units that was deferred by the reporting person. Each restricted stock unit represents a right to receive one share of MOD common stock. Shares will be delivered to the reporting person based on the reporting person's deferral election applicable to the restricted stock units.
VALVOLINE INC
Report date November 15, 2017 · Filed November 16, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| UnitSEC Table II · derivative / convertible security | Direct | 3,513 |
Reported balance
After 2017-11-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-11-15 · Grant · Acquired 3,513 · Balance 3,513 F1: Each unit represents a contingent right to receive one share of Valvoline common stock upon distribution. F2: Shares of Valvoline common stock or cash become payable in respect of the units upon the event of an unforeseeable emergency (as defined in the Valvoline 2016 Deferred Compensation Plan for Non-Employee Directors (the "Plan")) or the Reporting Person's death, disability or separation from service, in accordance with the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents a contingent right to receive one share of Valvoline common stock upon distribution.
F2: Shares of Valvoline common stock or cash become payable in respect of the units upon the event of an unforeseeable emergency (as defined in the Valvoline 2016 Deferred Compensation Plan for Non-Employee Directors (the "Plan")) or the Reporting Person's death, disability or separation from service, in accordance with the terms of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2016 Filed Oct 3, 2016 21:39 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063729 · form4.xml · nonDerivative · entry 1 WULFSOHN WILLIAM A · CIK 0001326402 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 19,803 F1 · balance_after: Includes 59 shares acquired on July 8, 2016 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 20:59 UTC | VALVOLINE INC VVV · Entity 1678 | PurchaseCommon Stock | 45,500 | $22.00 | $1,001,000.00 |
DisclosureSEC source: 0000950157-16-002266 · form4.xml · nonDerivative · entry 1 WULFSOHN WILLIAM A · CIK 0001326402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.